Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01889004Phase 4Completed
Phase 4, open-label trial of dexmedetomidine and propofol (2 arms), sponsored by University of Turku. Primary endpoint: Regional Cerebral Blood Flow at 2 months. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01889004.